PlainRecalls
FDA Drug Low Class III Terminated

Erythromycin Topical Gel, 2%, Net Wt. (a) 30 g,(NDC 52565-033-30) (b) 60 g,(NDC 52565-033-60) Rx Only, Manufactured by: Teligent Pharma, Inc. , Buena, NJ 08310,

Reported: July 28, 2021 Initiated: June 22, 2021 #D-0690-2021

Product Description

Erythromycin Topical Gel, 2%, Net Wt. (a) 30 g,(NDC 52565-033-30) (b) 60 g,(NDC 52565-033-60) Rx Only, Manufactured by: Teligent Pharma, Inc. , Buena, NJ 08310,

Reason for Recall

Failed Impurities/Degradation Specifications

Details

Recalling Firm
Teligent Pharma, Inc.
Units Affected
22,824 tubes
Distribution
Nationwide
Location
Buena, NJ

Frequently Asked Questions

What product was recalled?
Erythromycin Topical Gel, 2%, Net Wt. (a) 30 g,(NDC 52565-033-30) (b) 60 g,(NDC 52565-033-60) Rx Only, Manufactured by: Teligent Pharma, Inc. , Buena, NJ 08310,. Recalled by Teligent Pharma, Inc.. Units affected: 22,824 tubes.
Why was this product recalled?
Failed Impurities/Degradation Specifications
Which agency issued this recall?
This recall was issued by the FDA Drug on July 28, 2021. Severity: Low. Recall number: D-0690-2021.